ENTA
ENANTA PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$12.20
−2.56%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.52x
- Price / sales
- 5.45x
- Price / cash flow
- -10.06x
Enterprise value
- Enterprise value
- $221.5M
- EV / sales
- 3.39x
- EV / EBITDA
- -4.76x
- EV / EBIT
- -3.77x
- Market cap
- $355.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026